NCT03331263View on ClinicalTrials.gov

Single Dose CHG Pharmacokinetic Study

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

July 21, 2017

Primary Completion Date

August 6, 2017

Study Completion Date

August 6, 2017

Conditions

Surgical Skin Preparation

Interventions

DRUG

Chlorhexidine Gluconate

2% CHG

Trial Locations (1)

58104

Algorithme Pharma USA LLC, Fargo

Sponsors

Lead Sponsor

Medline Industries

All Listed Sponsors

lead

Medline Industries

INDUSTRY

NCT03331263 - Single Dose CHG Pharmacokinetic Study | Biotech Hunter | Biotech Hunter